Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects

变构调节 突变 拉帕蒂尼 突变体 蛋白激酶结构域 跨膜结构域 生物 生物信息学 突变 计算生物学 遗传学 癌症 基因 受体 曲妥珠单抗 乳腺癌
作者
Noboru Ishiyama,Matthew O’Connor,Andrei Salomatov,Darlene Romashko,Shalabh Thakur,Ahmet Mentes,Julia F. Hopkins,Garrett M. Frampton,Lee A. Albacker,Anna Kohlmann,Christopher Roberts,Elizabeth Buck
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (9): 1531-1542 被引量:15
标识
DOI:10.1158/0008-5472.can-21-0940
摘要

Amplification of HER2 can drive the proliferation of cancer cells, and several inhibitors of HER2 have been successfully developed. Recent advances in next-generation sequencing now reveal that HER2 is subject to mutation, with over 2,000 unique variants observed in human cancers. Several examples of oncogenic HER2 mutations have been described, and these primarily occur at allosteric sites outside the ATP-binding site. To identify the full spectrum of oncogenic HER2 driver mutations aside from a few well-studied mutations, we developed mutation-allostery-pharmacology (MAP), an in silico prediction algorithm based on machine learning. By applying this computational approach to 820 single-nucleotide variants, a list of 222 known and potential driver mutations was produced. Of these 222 mutations, 111 were screened by Ba/F3-retrovirus proliferation assays; 37 HER2 mutations were experimentally determined to be driver mutations, comprising 15 previously characterized and 22 newly identified oncogenic mutations. These oncogenic mutations mostly affected allosteric sites in the extracellular domain (ECD), transmembrane domain, and kinase domain of HER2, with only a single mutation in the HER2 orthosteric ATP site. Covalent homodimerization was established as a common mechanism of activation among HER2 ECD allosteric mutations, including the most prevalent HER2 mutation, S310F. Furthermore, HER2 allosteric mutants with enhanced covalent homodimerization were characterized by altered pharmacology that reduces the activity of existing anti-HER2 agents, including the mAb trastuzumab and the tyrosine kinase inhibitor lapatinib. Overall, the MAP-scoring and functional validation analyses provided new insights into the oncogenic activity and therapeutic targeting of HER2 mutations in cancer. SIGNIFICANCE: This study identified new oncogenic HER2 allosteric mutations, including ECD mutations that share covalent dimerization as a mechanism of oncogenicity, suggesting the need for novel inhibitors to treat HER2-mutant cancers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero的应助被细心又菡采纳,获得10
刚刚
DW的应助被楠小楠采纳,获得10
刚刚
Sea完成签到,获得积分10
刚刚
Lucas的应助被明理诗槐采纳,获得10
1秒前
科研通AI6.3的应助被楠小楠采纳,获得10
1秒前
123的应助被楠小楠采纳,获得100
1秒前
充电宝的应助被楠小楠采纳,获得10
1秒前
天天向上的应助被楠小楠采纳,获得10
1秒前
kkkk发布了新的文献求助10
1秒前
2秒前
ce完成签到 ,获得积分10
2秒前
molihuakai的应助被迷路依白采纳,获得10
3秒前
纯真大象完成签到,获得积分10
3秒前
yyds发布了新的文献求助50
4秒前
molihuakai的应助被D调的华丽采纳,获得10
4秒前
华仔的应助被D调的华丽采纳,获得10
4秒前
hzq完成签到,获得积分10
4秒前
CarryLJR的应助被龙澍采纳,获得10
4秒前
科目三的应助被D调的华丽采纳,获得10
4秒前
5秒前
华仔的应助被D调的华丽采纳,获得10
5秒前
脑洞疼的应助被D调的华丽采纳,获得10
5秒前
隐形曼青的应助被D调的华丽采纳,获得10
5秒前
orixero的应助被D调的华丽采纳,获得10
5秒前
5秒前
万能图书馆的应助被D调的华丽采纳,获得10
5秒前
小蘑菇的应助被D调的华丽采纳,获得10
6秒前
星辰大海的应助被砺行采纳,获得100
6秒前
molihuakai的应助被D调的华丽采纳,获得10
6秒前
小马甲的应助被soda采纳,获得10
6秒前
September发布了新的文献求助10
6秒前
6秒前
8秒前
kuku发布了新的文献求助10
11秒前
11秒前
今后的应助被许伟洋采纳,获得10
11秒前
Luo完成签到,获得积分10
11秒前
12秒前
MM发布了新的文献求助10
15秒前
Yaang发布了新的文献求助30
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178960
求助须知:如何正确求助?哪些是违规求助? 9569638
关于积分的说明 21805682
捐赠科研通 7774071
什么是DOI,文献DOI怎么找? 3432955
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478640